pSMP-Luc Citations (9)

Originally described in: Chromatin-modifying enzymes as modulators of reprogramming.
Onder TT, Kara N, Cherry A, Sinha AU, Zhu N, Bernt KM, Cahan P, Marcarci BO, Unternaehrer J, Gupta PB, Lander ES, Armstrong SA, Daley GQ Nature. 2012 Mar 4;483(7391):598-602. doi: 10.1038/nature10953. PubMed Journal

---

Articles Citing pSMP-Luc

Articles
MBD3 localizes at promoters, gene bodies and enhancers of active genes. Shimbo T, Du Y, Grimm SA, Dhasarathy A, Mav D, Shah RR, Shi H, Wade PA. PLoS Genet. 2013 Dec;9(12):e1004028. doi: 10.1371/journal.pgen.1004028. Epub 2013 Dec 26. PubMed Associated Plasmids pLgw-MBD3-V5-Dam
H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK. Olcina MM, Leszczynska KB, Senra JM, Isa NF, Harada H, Hammond EM. Oncogene. 2015 May 11. doi: 10.1038/onc.2015.134. PubMed
A SUV39H1-low chromatin state characterises and promotes migratory properties of cervical cancer cells. Rodrigues C, Pattabiraman C, Vijaykumar A, Arora R, Narayana SM, Kumar RV, Notani D, Varga-Weisz P, Krishna S. Exp Cell Res. 2019 May 15;378(2):206-216. doi: 10.1016/j.yexcr.2019.02.010. Epub 2019 Feb 14. PubMed
Systems-level analysis reveals multiple modulators of epithelial-mesenchymal transition and identifies DNAJB4 and CD81 as novel metastasis inducers in breast cancer. Uretmen Kagiali ZC, Sanal E, Karayel O, Polat AN, Saatci O, Ersan PG, Trappe K, Renard BY, Onder TT, Tuncbag N, Sahin O, Ozlu N. Mol Cell Proteomics. 2019 Jun 20. pii: RA119.001446. doi: 10.1074/mcp.RA119.001446. PubMed
Synaptic control of DNA methylation involves activity-dependent degradation of DNMT3A1 in the nucleus. Bayraktar G, Yuanxiang P, Confettura AD, Gomes GM, Raza SA, Stork O, Tajima S, Suetake I, Karpova A, Yildirim F, Kreutz MR. Neuropsychopharmacology. 2020 Nov;45(12):2120-2130. doi: 10.1038/s41386-020-0780-2. Epub 2020 Jul 29. PubMed
Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. Vatapalli R, Sagar V, Rodriguez Y, Zhao JC, Unno K, Pamarthy S, Lysy B, Anker J, Han H, Yoo YA, Truica M, Chalmers ZR, Giles F, Yu J, Chakravarti D, Carneiro B, Abdulkadir SA. Nat Commun. 2020 Aug 19;11(1):4153. doi: 10.1038/s41467-020-18013-7. PubMed
Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets. Vivarelli S, Falzone L, Ligresti G, Candido S, Garozzo A, Magro GG, Bonavida B, Libra M. Int J Mol Sci. 2020 Sep 3;21(17). pii: ijms21176446. doi: 10.3390/ijms21176446. PubMed
YY1 Silencing Induces 5-Fluorouracil-Resistance and BCL2L15 Downregulation in Colorectal Cancer Cells: Diagnostic and Prognostic Relevance. Vivarelli S, Falzone L, Candido S, Bonavida B, Libra M. Int J Mol Sci. 2021 Aug 6;22(16). pii: ijms22168481. doi: 10.3390/ijms22168481. PubMed
BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming. Sevinc K, Sevinc GG, Cavga AD, Philpott M, Kelekci S, Can H, Cribbs AP, Yildiz AB, Yilmaz A, Ayar ES, Arabaci DH, Dunford JE, Ata D, Sigua LH, Qi J, Oppermann U, Onder TT. Stem Cell Reports. 2022 Dec 13;17(12):2629-2642. doi: 10.1016/j.stemcr.2022.10.005. Epub 2022 Nov 3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.